2-{[3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)pyridin-4-yl]thio}acetic acid

ID: ALA5282615

Chembl Id: CHEMBL5282615

Max Phase: Preclinical

Molecular Formula: C17H16N2O3S

Molecular Weight: 328.39

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CSc1ccncc1C(=O)N1CCc2ccccc2C1

Standard InChI:  InChI=1S/C17H16N2O3S/c20-16(21)11-23-15-5-7-18-9-14(15)17(22)19-8-6-12-3-1-2-4-13(12)10-19/h1-5,7,9H,6,8,10-11H2,(H,20,21)

Standard InChI Key:  VYGPRDVAXOXCBB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5282615

    ---

Associated Targets(Human)

SLC22A12 Tclin Solute carrier family 22 member 12 (799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 328.39Molecular Weight (Monoisotopic): 328.0882AlogP: 2.46#Rotatable Bonds: 4
Polar Surface Area: 70.50Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.19CX Basic pKa: 4.05CX LogP: 0.78CX LogD: -1.76
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.87Np Likeness Score: -1.56

References

1. Zhang J, Dong Y, Gao S, Zhang X, Liao H, Shi X, Zhang Z, Zhao T, Liang R, Qi D, Wu T, Pang J, Liu X, Zhan P..  (2022)  Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors.,  244  [PMID:36219903] [10.1016/j.ejmech.2022.114816]

Source